MGRC staff at work in the company's lab. - Filepic
KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd
was awarded a Covid-19 surveillance contract by the Health Ministry's biomedical research arm, the Institute of Medical Research.
"We are pleased to support IMR and MOH in this important effort to monitor the evolution of the COVID-19 virus, its variants and sub-variants.
"With our expertise and knowledge in genomics and bioinformatics, we can help IMR track and trace the virus for any variants of concern that the Government needs to be informed of as well as prepare for." said Malaysian Genomics executive director Datuk Alvin Nesakumar in a statement.
The genomics and biopharmaceutical specialist, whose cell laboratory is the only privately-owned BioSafety Level 2 (BSL-2) facility in Malaysia with the Current Good Manufacturing Practice (cGMP) certification, said it is moving towards becoming a premier healthcare provider through the production of CAR T-cells for cancer immunotherapy for solid cancers, as well as other cell engineering services.
BSL-2 and cGMP certifications indicate that a laboratory facility has stringent measures for biocontainment standards and ultra-pure laboratory environments to safely work on human cells.
